LTS-Lohmann Therapie-System AG

About LTS-Lohmann Therapie-System AG

LTS Lohmann Therapie-Systeme AG is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) for the pharmaceutical industry. LTS’s innovation model consists of both, partner projects and proprietary initiatives currently encompassing more than 20 marketed products and a deep and diverse pipeline of development projects targeting multiple disease indications with unmet need. LTS maintains its leading position through the continuous refinement of its core TTS and OTF technologies and by advancing emerging drug delivery technologies. A specific focus lies on Mircro Array Patches for the transdermal delivery of large molecules and biological actives.
Founded in 1984, LTS operates today from two sites in Andernach, Germany and West Caldwell, NJ, USA and a representation in Shanghai, China.




  • DE
  • 2015
    On CPHI since
Company types
Contract Service
Manufacturer/Innovator
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from LTS-Lohmann Therapie-System AG (2)

  • Transdermal Therapeutic Systems

    Product Transdermal Therapeutic Systems

    Transdermal patches or transdermal therapeutic systems (TTS) are drug delivery systems that are applied directly to the skin. The active substance is absorbed by the skin and distributed through the body via the bloodstream.
  • Oral Thin Films

    Product Oral Thin Films

    Oral thin films are loaded with active substances. The Thin films are taken orally and dissolve immediately in the mouth or are applied to the mucosa. For transmucosal films, the active substance enters the bloodstream directly via the oral mucosa, without having to first pass through the gastrointestinal tra...